515 filings
Page 5 of 26
8-K
mnvdrnszefg3zr8z k6i
1 Nov 18
Other Events
9:30am
8-K
xubkywtaahm9nl7pu2qh
16 Oct 18
Changes in Control of Registrant
4:05pm
8-K
et672vu
12 Oct 18
Departure of Directors or Certain Officers
4:18pm
424B3
l1a2zvq
9 Oct 18
Prospectus supplement
4:16pm
8-K
gdizhqcxq984foqy7yow
28 Sep 18
Entry into a Material Definitive Agreement
4:00pm
424B3
c2vlt
21 Sep 18
Prospectus supplement
4:16pm
8-K
nqssea ih
7 Sep 18
Entry into a Material Definitive Agreement
12:00am
D
rvy 5b8jx70roekp5
17 Aug 18
$5.14M in equity, sold $5.14M, 13 investors
4:42pm
8-K
je76avel
3 Aug 18
Entry into a Material Definitive Agreement
9:30am
424B3
e7m4bswh60
3 Aug 18
Prospectus supplement
9:16am
8-K
zr0yycte4deyhh4557b
5 Jul 18
Entry into a Material Definitive Agreement
12:00am
8-K
z8wfnbqf
14 May 18
GT Biopharma Announces DR. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company
4:01pm
8-K
j70f9zguqyu
27 Apr 18
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
4:01pm
EFFECT
fluwywyd
22 Mar 18
Notice of effectiveness
12:00am
EFFECT
ju6dbc12
22 Mar 18
Notice of effectiveness
12:00am
CORRESP
t6cr8hbv
21 Mar 18
Correspondence with SEC
12:00am